Health Care M&A Weekly Deals, The Week Ending April 6, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report.

This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search.

Biotechnology
Acquirer Target Price
Agilent Technologies Inc. Lasergen, Inc. $105 million
MedImmune Exclusive license to antibody products $10 million
Ferring Pharmaceuticals Rebiotix Inc. N/A
UCB S.A. Element Genomics $30 million
Novo Nordisk A/S Exclusive license to sickle cell disease program N/A
BB100, LLC Exclusive worldwide license to monoclonal antibodies N/A
eHealth
Acquirer Target Price
SCI Solutions DatStat N/A
LLR Partners MedBridge Inc. N/A
HGS Population Health LLC, USA AxisPoint Health N/A
Veritas Capital Value-Based Care Division of GE Healthcare $1.05 billion
Home Health Care & Hospice
Acquirer Target Price
Addus HomeCare Corporation Arcadia Home Care & Staffing $18.5 million
Long-Term Care
Acquirer Target Price
Operating group Larchwood Village & West Park Commons $11 million
Private equity firm Garden Court Retirement Community $50.5 million
New York-based owner Nu-Roc Community Healthcare N/A
The Ensign Group, Inc. Peoria Post Acute and Rehabilitation N/A
Real estate investor Silver Pines Nursing & Rehabilitation $3.5 million
Private equity firm The Willows of Easley $14.5 million
MBK Senior Living Quail Park of Klamath Falls N/A
Regional Owner/Operator Skilled Nursing Facility $18.75 million
Medical Devices
Acquirer Target Price
APAX Partners Healthium MedTech Private Limited N/A
Boston Scientific Corporation Securus Medical Group, Inc. $40 million
NN, Inc. PMG International Holdings Corporation $375 million
American Diversified Holdings Corporation Brazos Biomedical, LLC N/A
Pharmaceuticals
Acquirer Target Price
Roche Inception Neuroscience Program N/A
Cannabis Wheaton Income Corp. Dosecann Inc. $29.8 million
Terns Pharmaceuticals Inc. Exclusive rights to 3 NASH assets N/A
Pint Pharma Exclusive license to Nerlynx in Latin America N/A
Corona Remedies Pvt Ltd 2 brands from Abbott India Ltd N/A
Rhythm Pharmaceuticals, Inc. Exclusive global rights to T-3525770 $5 million
Physician Medical Groups
Acquirer Target Price
RadNet, Inc. 5 Imaging centers N/A
Mercy Metro Imaging N/A
St. David’s HealthCare The Austin Diagnostic Clinic N/A
Mednax, Inc. Children’s Urology Associates, P.A. N/A
American Hearing + Audiology Connect Hearing’s hearing care centers N/A
Other
Acquirer Target Price
Frontage Laboratories, Inc. Concord Biosciences N/A
Empower Health Services, LLC Health Maintenance Institute of Illinois, Inc. Merger
Civitas Solutions, Inc. 2 Adult Day Health Centers N/A
     

 

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *